Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Fonteneau

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cellsN Gervois, N Labarriere, S Le Guiner, et al.
The European Respiratory Journal|May 5, 2011
A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesotheliomaS Leclercq, F Gueugnon, B Boutin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcriptionN Labarriere, E Diez, M C Pandolfino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analoguesD Valmori, J F Fonteneau, C M Lizana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patientsM V Dhodapkar, J W Young, P B Chapman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cellsM Larsson, D Messmer, S Somersan, et al.
International Immunology|December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analoguesD Valmori, J F Fonteneau, S Valitutti, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cellsN Gervois, N Labarriere, S Le Guiner, et al.
The European Respiratory Journal|May 5, 2011
A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesotheliomaS Leclercq, F Gueugnon, B Boutin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcriptionN Labarriere, E Diez, M C Pandolfino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analoguesD Valmori, J F Fonteneau, C M Lizana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patientsM V Dhodapkar, J W Young, P B Chapman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cellsM Larsson, D Messmer, S Somersan, et al.
International Immunology|December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analoguesD Valmori, J F Fonteneau, S Valitutti, et al.
Pageof 2